COP has been the subject of a number of other reports. Baader Bank set a €52.00 ($61.18) price objective on shares of Compugroup Medical SE and gave the stock a buy rating in a report on Saturday, May 20th. HSBC Holdings plc set a €60.00 ($70.59) price target on shares of Compugroup Medical SE and gave the stock a buy rating in a research note on Wednesday, July 5th. Warburg Research set a €52.00 ($61.18) price target on shares of Compugroup Medical SE and gave the stock a neutral rating in a research note on Tuesday, June 20th. Finally, Berenberg Bank set a €53.00 ($62.35) price target on shares of Compugroup Medical SE and gave the stock a neutral rating in a research note on Friday, August 4th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company has a consensus rating of Buy and an average target price of €55.40 ($65.18).
Shares of Compugroup Medical SE (ETR:COP) opened at 50.001 on Monday. The stock’s 50 day moving average price is €49.71 and its 200 day moving average price is €45.20. Compugroup Medical SE has a one year low of €36.21 and a one year high of €52.80. The stock has a market capitalization of €2.49 billion and a P/E ratio of 54.646.
Compugroup Medical SE Company Profile
Compugroup Medical SE is a Germany-based software developer. The Company focuses on software solutions to the healthcare industry, including physicians, pharmacies, health insurances, laboratories, hospitals and rehabilitation and care facilities. Its activities are divided into three segments: Health Provider Services I, Health Provider Services II and Health Connectivity Services.
What are top analysts saying about Compugroup Medical SE? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Compugroup Medical SE and related companies.